好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Comparison of Relapse Rates in Multiple Sclerosis Patients Switching from Glatiramer Acetate to Fingolimod versus Those Remaining on Glatiramer Acetate
Multiple Sclerosis
(-)
254
Authors/Disclosures

PRESENTER 		No disclosure on file
Gourab Datta No disclosure on file
Tara Nazareth (Mallinckrodt Pharmaceuticals) No disclosure on file
No disclosure on file
No disclosure on file
Emily A. Johnson No disclosure on file
No disclosure on file
Rahul Sasane, PhD (Cerevel Therapeutics) Dr. Sasane has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Sasane has stock in Cerevel Therapeutics.